IC-P-113: FDG-PET NORMATIVE DATA IN COGNITIVELY HEALTHY AGING
نویسندگان
چکیده
منابع مشابه
FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging
One of the key research agenda of the field of aging is investigation of presymptomatic Alzheimer's disease (AD). Furthermore, abnormalities in brain glucose metabolism (as measured by FDG-PET) have been reported among cognitively normal elderly persons. However, little is known about the association of FDG-PET abnormalities with neuropsychiatric symptoms (NPS) in a population-based setting. Th...
متن کاملFDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
Having a parent affected by late-onset Alzheimer's disease (AD) is a major risk factor for cognitively normal (NL) individuals. This study explores the potential of PET with 18F-FDG and the amyloid- β (Aβ) tracer 11C-Pittsburgh Compound B (PiB) for detection of individual risk in NL adults with AD-parents. METHODS FDG- and PiB-PET was performed in 119 young to late-middle aged NL individuals ...
متن کاملGender differences in healthy aging and Alzheimer's Dementia: A 18 F-FDG-PET study of brain and cognitive reserve.
Cognitive reserve (CR) and brain reserve (BR) are protective factors against age-associated cognitive decline and neurodegenerative disorders. Very limited evidence exists about gender effects on brain aging and on the effect of CR on brain modulation in healthy aging and Alzheimer's Dementia (AD). We investigated gender differences in brain metabolic activity and resting-state network connecti...
متن کاملFDG-PET in lymphoma
FDG-PET has changed lymphoma management at staging and for response assessment due to its capability to improve disease characterization and treatment selection. New recommendations have been made by the ICML working group in 2014. FDG-PET is now recommended for staging in the vast majority of lymphoma since almost all types of lymphoma are FDG-avid. It has been shown recently that FDG-PET due ...
متن کاملFDG PET in Dementia
Positron emission tomography (PET) is a branch of Nuclear Medicine, a new novel way of functional imaging using radioisotopes, which has a significant role in all aspects of dementia-early diagnosis, differential diagnosis, and the assessment of drug treatment. [18F] Fluorodeoxyglucose (FDG) allows measurement of cerebral glucose metabolism both qualitatively and quantitatively. The metabolic a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alzheimer's & Dementia
سال: 2019
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2019.06.4227